Aim: Tumour suppressor gene p53 is a common target in carcinogenesis, reported to be altered and functionally inactive in 70 of human cancers. Although p53 mutations are less commonly present in haematological malignancies when compared with other solid tumours, they have been reported in histological transformation of follicular lymphoma. We aimed to investigate the frequency of p53 gene alterations in paraffin-embedded tissue using commercially available PCR-SSCP, and to correlate the results with P53 protein expression by immunohistochemistry. Methods: Surgical samples from seven patients with a total of 17 sequential biopsies were retrieved for the study of p53 gene expression using immunohistochemical stain, and gene status by PCR-SSCP...
One hundred and eighty-eight infiltrating ductal carcinomas of the breast were examined immunohistoc...
p53 mutations are found in a wide variety of cancers, including hematologic malignancies. These alte...
Lung resections from 50 Chinese patients in Hong Kong diagnosed as having non-small cell lung carcin...
The majority of low-grade non-Hodgkin's lymphomas (NHL) undergo clinical progression toward intermed...
The majority of low-grade non-Hodgkin's lymphomas (NHL) undergo clinical progression toward intermed...
Mutations in p53 exons 5-8 are found in 40-50% of breast carcinomas. We performed a retrospective an...
p53 tumor-suppressor gene which encodes a nuclear phosphoprotein that arrests cell cycle progress at...
Immunohistochemistry staining of p53 is a cheap and simple method to detect aberrant function of p53...
TP53 gene mutations, one of the most common alterations described in human tumors, have also been de...
The p53 gene is located on the small arm of chromosome 17 and mutations or hyperexpression are found...
To achieve a more accurate diagnosis in the first aspiration biopsy from breast tumor, p53 gene muta...
Alterations in p53 were analyzed by immunochemistry in 131 lesions from 108 patients and by polymera...
The most frequently mutated tumor suppressor gene found in human cancer is p53. In a normal situatio...
I.F. 1.581 Abstract: Aim-To correlate immunohistochemical staining with single strand conformation p...
Overexpression of the nuclear phosphoprotein p53 is one of the most frequently detected abnormalitie...
One hundred and eighty-eight infiltrating ductal carcinomas of the breast were examined immunohistoc...
p53 mutations are found in a wide variety of cancers, including hematologic malignancies. These alte...
Lung resections from 50 Chinese patients in Hong Kong diagnosed as having non-small cell lung carcin...
The majority of low-grade non-Hodgkin's lymphomas (NHL) undergo clinical progression toward intermed...
The majority of low-grade non-Hodgkin's lymphomas (NHL) undergo clinical progression toward intermed...
Mutations in p53 exons 5-8 are found in 40-50% of breast carcinomas. We performed a retrospective an...
p53 tumor-suppressor gene which encodes a nuclear phosphoprotein that arrests cell cycle progress at...
Immunohistochemistry staining of p53 is a cheap and simple method to detect aberrant function of p53...
TP53 gene mutations, one of the most common alterations described in human tumors, have also been de...
The p53 gene is located on the small arm of chromosome 17 and mutations or hyperexpression are found...
To achieve a more accurate diagnosis in the first aspiration biopsy from breast tumor, p53 gene muta...
Alterations in p53 were analyzed by immunochemistry in 131 lesions from 108 patients and by polymera...
The most frequently mutated tumor suppressor gene found in human cancer is p53. In a normal situatio...
I.F. 1.581 Abstract: Aim-To correlate immunohistochemical staining with single strand conformation p...
Overexpression of the nuclear phosphoprotein p53 is one of the most frequently detected abnormalitie...
One hundred and eighty-eight infiltrating ductal carcinomas of the breast were examined immunohistoc...
p53 mutations are found in a wide variety of cancers, including hematologic malignancies. These alte...
Lung resections from 50 Chinese patients in Hong Kong diagnosed as having non-small cell lung carcin...